|
1
|
Lopez-Garcia MA, Geyer FC, Lacroix-Triki
M, Marchió C and Reis-Filho JS: Breast cancer precursors revisited:
molecular features and progression pathways. Histopathology.
57:171–192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gong G, DeVries S, Chew KL, Cha I, Ljung
BM and Waldman FM: Genetic changes in paired atypical and usual
ductal hyperplasia of the breast by comparative genomic
hybridization. Clin Cancer Res. 7:2410–2414. 2001.PubMed/NCBI
|
|
3
|
Pinder SE and Ellis IO: The diagnosis and
management of pre-invasive breast disease: ductal carcinoma in situ
(DCIS) and atypical ductal hyperplasia (ADH)-current definitions
and classification. Breast Cancer Res. 5:254–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simpson PT, Gale T, Reis-Filho JS, Jones
C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S,
Ellis IO and Lakhani SR: Columnar cell lesions of the breast: the
missing link in breast cancer progression A morphological and
molecular analysis. Am J Surg Pathol. 29:734–746. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simpson PT, Reis-Filho JS, Gale T and
Lakhani SR: Molecular evolution of breast cancer. J Pathol.
205:248–254. 2005. View Article : Google Scholar
|
|
6
|
Mastracci TL, Shadeo A, Colby SM, Tuck AB,
O’Malley FP, Bull SB, Lam WL and Andrulis IL: Genomic alterations
in lobular neoplasia: a microarray comparative genomic
hybridization signature for early neoplastic proliferation in the
breast. Genes Chromosomes Cancer. 45:1007–1017. 2006. View Article : Google Scholar
|
|
7
|
Amari M, Suzuki A, Moriya T, Yoshinaga K,
Amano G, Sasano H, Ohuchi N, Satomi S and Horii A: LOH analyses of
premalignant and malignant lesions of human breast: frequent LOH in
8p, 16q, and 17q in atypical ductal hyperplasia. Oncol Rep.
6:1277–1280. 1999.PubMed/NCBI
|
|
8
|
Iqbal M, Davies MP, Shoker BS, Jarvis C,
Sibson DR and Sloane JP: Subgroups of non-atypical hyperplasia of
breast defined by proliferation of oestrogen receptor-positive
cells. J Pathol. 193:333–338. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shaaban AM, O’Neill PA, Davies MP, Sibson
R, West CR, Smith PH and Foster CS: Declining estrogen
receptor-beta expression defines malignant progression of human
breast neoplasia. Am J Surg Pathol. 27:1502–1512. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ariga N, Suzuki T, Moriya T, Kimura M,
Inoue T, Ohuchi N and Sasano H: Progesterone receptor A and B
isoforms in the human breast and its disorders. Jpn J Cancer Res.
92:302–308. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohsin SK, O’Connell P, Allred DC and
Libby AL: Biomarker profile and genetic abnormalities in lobular
carcinoma in situ. Breast Cancer Res Treat. 90:249–256. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oh YL, Choi JS, Song SY, Ko YH, Han BK,
Nam SJ and Yang JH: Expression of p21Waf1, p27Kip1 and cyclin D1
proteins in breast ductal carcinoma in situ: Relation with
clinicopathologic characteristics and with p53 expression and
estrogen receptor status. Pathol Int. 51:94–99. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dawson SJ, Makretsov N, Blows FM, Driver
KE, Provenzano E, Le Quesne J, Baglietto L, Severi G, Giles GG,
McLean CA, Callagy G, Green AR, Ellis I, Gelmon K, Turashvili G,
Leung S, Aparicio S, Huntsman D, Caldas C and Pharoah P: BCL2 in
breast cancer: a favourable prognostic marker across molecular
subtypes and independent of adjuvant therapy received. Br J Cancer.
103:668–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siziopikou KP, Prioleau JE, Harris JR and
Schnitt SJ: bcl-2 expression in the spectrum of preinvasive breast
lesions. Cancer. 77:499–506. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Megha T, Ferrari F, Benvenuto A, Bellan C,
Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L and Tosi
P: p53 mutation in breast cancer. Correlation with cell kinetics
and cell of origin. J Clin Pathol. 55:461–466. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zagouri F, Sergentanis TN and Zografos GC:
Precursors and preinvasive lesions of the breast: the role of
molecular prognostic markers in the diagnostic and therapeutic
dilemma. World J Surg Oncol. 5:572007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nass SJ, Herman JG, Gabrielson E, Iversen
PW, Parl FF, Davidson NE and Graff JR: Aberrant methylation of the
estrogen receptor and E-cadherin 5′ CpG islands increases with
malignant progression in human breast cancer. Cancer Res.
60:4346–4348. 2000.
|
|
18
|
Sen S and Hopwood V: Molecular cytogenetic
evidence for multistep tumorigenesis: implications for risk
assessment and early detection. Cancer Biomark. 9:113–132.
2010.PubMed/NCBI
|
